MedPath

CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight

Completed
Conditions
Healthy
Registration Number
NCT02611947
Lead Sponsor
Erasme University Hospital
Brief Summary

Various indexes have been proposed to quantify both pulmonary emphysema and airways disease on chest CT scans. It is unknown whether these indexes should be consider in absolute values or as compared to predicted normal values. The purposes of the present study is thus : a) to measure these indexes at CT in healthy volunteers; b) to investigate their relations with gender, height and weight.

Detailed Description

87 healthy volunteers performed consecutively a low-dose chest CT scan and pulmonary function tests:

1. On chest CT scans, indexes reflecting pulmonary emphysema and airways measurements have been computed by using dedicated softwares. Each of our three readers performed two reading sessions.

Relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units; luminal area and wall thickness in third and fourth generations airways were recorded.

2. Pulmonary function tests were performed: vital capacity, forced vital capacity , functional residual capacity, total lung capacity, residual volume, forced expiratory volume in one second, and diffusion lung capacity for carbon monoxide were recorded (either in absolute values and percentage of predicted values).

CT indexes were compared with gender, height and weight.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Never smoked.
  • No respiratory infection in the 4 weeks before the begin of the study.
  • No history of pulmonary resection.
  • No active malignancy or malignancy of any organ system within the past 5 years.
Exclusion Criteria
  • no exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CT index - RA960 (%)4 hours

From acquired data, images were reconstructed using a soft algorithm. On these soft images, the relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units was computed (expressed in %), as an index representative of pulmonary emphysema extent.

CT index - LA4th (mm2)4 hours

From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in fourth generations of airways (expressed in mm2).

CT index - LA3rd (mm2)4 hours

From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in third generations of airways (expressed in mm2).

CT index - WT4th (mm)4 hours

From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in fourth generations of airways (expressed in mm).

CT index - WT3rd (mm)4 hours

From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in third generations of airways (expressed in mm).

Secondary Outcome Measures
NameTimeMethod
Pulmonary function tests - TLC (l)4 hours

Total lung capacity was measured (expressed in l).

Pulmonary function tests - DLCO (ml/min/ mmHg)4 hours

Diffusion lung capacity for carbon monoxide was measured (expressed in ml/min/ mmHg)

Pulmonary function tests - VC (l)4 hours

Vital capacity was measured (expressed in l).

Pulmonary function tests - FRC (l)4 hours

Functional residual capacity capacity was measured (expressed in l).

Pulmonary function tests - RV (l)4 hours

Residual volume was measured (expressed in l).

Pulmonary function tests - FVC (l)4 hours

Forced vital capacity was measured (expressed in l).

Pulmonary function tests - FEV1 (l)4 hours

Forced expiratory volume in one second was measured (expressed in l).

Trial Locations

Locations (1)

Erasme University Hospital

🇧🇪

Brussels, Belgium

Erasme University Hospital
🇧🇪Brussels, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.